Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72


Fecal IgA Levels Are Determined by Strain-Level Differences in Bacteroides ovatus and Are Modifiable by Gut Microbiota Manipulation.

Yang C, Mogno I, Contijoch EJ, Borgerding JN, Aggarwala V, Li Z, Siu S, Grasset EK, Helmus DS, Dubinsky MC, Mehandru S, Cerutti A, Faith JJ.

Cell Host Microbe. 2020 Feb 11. pii: S1931-3128(20)30055-X. doi: 10.1016/j.chom.2020.01.016. [Epub ahead of print]


Vedolizumab therapy in common variable immune deficiency associated enteropathy: A case series.

Sifers T, Hirten R, Mehandru S, Ko HM, Colombel JF, Cunningham-Rundles C.

Clin Immunol. 2020 Feb 11;212:108362. doi: 10.1016/j.clim.2020.108362. [Epub ahead of print]


Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample study.

Kayal M, Saha A, Poojary P, Paramsothy S, Hirten R, Cohen L, Gallinger Z, Mehandru S, Cho J, Greenstein A, Nadkarni G, Dubinsky MC, Colombel JF, Cohen B, Ungaro R.

Int J Colorectal Dis. 2019 Oct;34(10):1771-1779. doi: 10.1007/s00384-019-03375-2. Epub 2019 Sep 11.


Acute kidney injury secondary to thrombotic microangiopathy associated with idiopathic hypereosinophilic syndrome: a case report and review of the literature.

Curras-Martin D, Patel S, Qaisar H, Mehandru SK, Masud A, Hossain MA, Lamba GS, Dounis H, Levitt M, Asif A.

J Med Case Rep. 2019 Sep 5;13(1):281. doi: 10.1186/s13256-019-2187-4. Review.


Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice.

Torres J, Hu J, Seki A, Eisele C, Nair N, Huang R, Tarassishin L, Jharap B, Cote-Daigneault J, Mao Q, Mogno I, Britton GJ, Uzzan M, Chen CL, Kornbluth A, George J, Legnani P, Maser E, Loudon H, Stone J, Dubinsky M, Faith JJ, Clemente JC, Mehandru S, Colombel JF, Peter I.

Gut. 2020 Jan;69(1):42-51. doi: 10.1136/gutjnl-2018-317855. Epub 2019 Apr 29.


The Revolution within a Revolution: Personal Experiences of a Young Interventional Radiologist.

Mehandru S.

Semin Intervent Radiol. 2019 Mar;36(1):29-31. doi: 10.1055/s-0039-1679950. Epub 2019 Mar 29. Review.


Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases.

Fenster M, Ungaro RC, Hirten R, Gallinger Z, Cohen L, Atreja A, Mehandru S, Colombel JF, Cohen BL.

Clin Gastroenterol Hepatol. 2020 Jan;18(1):257-258. doi: 10.1016/j.cgh.2019.03.030. Epub 2019 Mar 22.


Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44.

Shan M, Carrillo J, Yeste A, Gutzeit C, Segura-Garzón D, Walland AC, Pybus M, Grasset EK, Yeiser JR, Matthews DB, van de Veen W, Comerma L, He B, Boonpiyathad T, Lee H, Blanco J, Osborne LC, Siracusa MC, Akdis M, Artis D, Mehandru S, Sampson HA, Berin MC, Chen K, Cerutti A.

Immunity. 2018 Oct 16;49(4):709-724.e8. doi: 10.1016/j.immuni.2018.08.013. Epub 2018 Oct 2.


Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1-infected individuals.

Uzzan M, Tokuyama M, Rosenstein AK, Tomescu C, SahBandar IN, Ko HM, Leyre L, Chokola A, Kaplan-Lewis E, Rodriguez G, Seki A, Corley MJ, Aberg J, La Porte A, Park EY, Ueno H, Oikonomou I, Doron I, Iliev ID, Chen BK, Lui J, Schacker TW, Furtado GC, Lira SA, Colombel JF, Horowitz A, Lim JK, Chomont N, Rahman AH, Montaner LJ, Ndhlovu LC, Mehandru S.

Sci Transl Med. 2018 Oct 3;10(461). pii: eaau4711. doi: 10.1126/scitranslmed.aau4711.


The current state of the art for biological therapies and new small molecules in inflammatory bowel disease.

Paramsothy S, Rosenstein AK, Mehandru S, Colombel JF.

Mucosal Immunol. 2018 Nov;11(6):1558-1570. doi: 10.1038/s41385-018-0050-3. Epub 2018 Jun 15. Review.


Vagal dysfunction and small intestinal bacterial overgrowth: novel pathways to chronic inflammation in HIV.

Robinson-Papp J, Nmashie A, Pedowitz E, Benn EKT, George MC, Sharma S, Murray J, Machac J, Heiba S, Mehandru S, Kim-Schulze S, Navis A, Elicer I, Morgello S.

AIDS. 2018 Jun 1;32(9):1147-1156. doi: 10.1097/QAD.0000000000001802.


Pregnancy and hemodialysis access: A case for patient satisfaction in favor of a tunneled dialysis catheter.

Mehandru S, Haroon A, Masud A, Patel M, Sadiang-Abay E, Costanzo EJ, Vachharajani TJ.

J Vasc Access. 2018 Nov;19(6):663-666. doi: 10.1177/1129729817747540. Epub 2018 Mar 5.


Efficient long-term depletion of CD20+ B cells by rituximab does not affect gut-resident plasma cells.

Uzzan M, Ko HM, Rosenstein AK, Pourmand K, Colombel JF, Mehandru S.

Ann N Y Acad Sci. 2018 Mar;1415(1):5-10. doi: 10.1111/nyas.13577. Epub 2017 Dec 31.


Management of hypertension in patients during percutaneous dialysis access interventions.

Gandhi BV, Patel TB, Costanzo EJ, Masud A, Mehandru S, Salman L.

J Vasc Access. 2017 Sep 11;18(5):363-365. doi: 10.5301/jva.5000779. Epub 2017 Jul 27.


Human Secretory IgM Emerges from Plasma Cells Clonally Related to Gut Memory B Cells and Targets Highly Diverse Commensals.

Magri G, Comerma L, Pybus M, Sintes J, Lligé D, Segura-Garzón D, Bascones S, Yeste A, Grasset EK, Gutzeit C, Uzzan M, Ramanujam M, van Zelm MC, Albero-González R, Vazquez I, Iglesias M, Serrano S, Márquez L, Mercade E, Mehandru S, Cerutti A.

Immunity. 2017 Jul 18;47(1):118-134.e8. doi: 10.1016/j.immuni.2017.06.013. Epub 2017 Jul 11.


Ischemic monomelic neuropathy: a long-term follow-up of two cases.

Singh V, Qaisar H, Masud A, Mehandru S, Sadiang-Abay E, Costanzo EJ, Salman L.

J Vasc Access. 2017 Nov 17;18(6):e89-e91. doi: 10.5301/jva.5000743.


Subcutaneous defibrillators for dialysis patients.

Vachharajani TJ, Salman L, Costanzo EJ, Mehandru SK, Patel M, Calderon DM, Mathew RO, Sidhu MS, Asif A.

Hemodial Int. 2018 Jan;22(1):4-8. doi: 10.1111/hdi.12577. Epub 2017 Jun 23. Review.


Arteriovenous fistula maturation in patients with permanent access created prior to or after hemodialysis initiation.

Duque JC, Martinez L, Tabbara M, Dvorquez D, Mehandru SK, Asif A, Vazquez-Padron RI, Salman LH.

J Vasc Access. 2017 May 15;18(3):185-191. doi: 10.5301/jva.5000662. Epub 2017 Feb 15.


Brief Report: The Relationship Between Injection Drug Use Risk Behaviors and Markers of Immune Activation.

Deren S, Cleland CM, Lee H, Mehandru S, Markowitz M.

J Acquir Immune Defic Syndr. 2017 May 1;75(1):e8-e12. doi: 10.1097/QAI.0000000000001270.


Ulcerative colitis.

Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF.

Lancet. 2017 Apr 29;389(10080):1756-1770. doi: 10.1016/S0140-6736(16)32126-2. Epub 2016 Dec 1. Review.


Crohn's disease.

Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L.

Lancet. 2017 Apr 29;389(10080):1741-1755. doi: 10.1016/S0140-6736(16)31711-1. Epub 2016 Dec 1. Review.


B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Uzzan M, Colombel JF, Cerutti A, Treton X, Mehandru S.

Dig Dis Sci. 2016 Dec;61(12):3407-3424. Epub 2016 Sep 21. Review.


Corrigendum: Statins Associated with Decreased Risk of New Onset Inflammatory Bowel Disease.

Ungaro R, Chang HL, Cote-Daigneaut J, Mehandru S, Atreja A, Colombel JF.

Am J Gastroenterol. 2016 Sep;111(9):1370. doi: 10.1038/ajg.2016.301. No abstract available.


Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.

Markowitz M, Deren S, Cleland C, La Mar M, Silva E, Batista P, St Bernard L, Gettie N, Rodriguez K, Evering TH, Lee H, Mehandru S.

J Infect Dis. 2016 Nov 1;214(9):1376-1382. Epub 2016 Aug 11.


Challenges in Recruiting People Who Use Drugs for HIV-Related Biomedical Research: Perspectives from the Field.

Batista P, Deren S, Banfield A, Silva E, Cruz M, Garnes P, Cleland CM, Mehandru S, LaMar M, Markowitz M.

AIDS Patient Care STDS. 2016 Aug;30(8):379-84. doi: 10.1089/apc.2016.0135.


Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.

Ungaro R, Chang HL, Côté-Daigneault J, Mehandru S, Atreja A, Colombel JF.

Am J Gastroenterol. 2016 Oct;111(10):1416-1423. doi: 10.1038/ajg.2016.233. Epub 2016 Jun 14. Erratum in: Am J Gastroenterol. 2016 Sep;111(9):1370.


Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD).

Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C.

Curr Gastroenterol Rep. 2016 Apr;18(4):17. doi: 10.1007/s11894-016-0491-3. Review.


Behavioural, Mucosal and Systemic Immune Parameters in HIV-infected and Uninfected Injection Drug Users.

Mehandru S, Deren S, Kang SY, Banfield A, Garg A, Garmon D, LaMar M, Evering TH, Markowitz M.

J Addict Res Ther. 2015;6(4):1-8.


Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.

Côté-Daigneault J, Mehandru S, Ungaro R, Atreja A, Colombel JF.

Inflamm Bowel Dis. 2016 Mar;22(3):724-32. doi: 10.1097/MIB.0000000000000640. Review.


A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.

Ruane D, Do Y, Brane L, Garg A, Bozzacco L, Kraus T, Caskey M, Salazar A, Trumpheller C, Mehandru S.

Mucosal Immunol. 2016 Sep;9(5):1340-52. doi: 10.1038/mi.2015.133. Epub 2016 Jan 6.


Microbiota regulate the ability of lung dendritic cells to induce IgA class-switch recombination and generate protective gastrointestinal immune responses.

Ruane D, Chorny A, Lee H, Faith J, Pandey G, Shan M, Simchoni N, Rahman A, Garg A, Weinstein EG, Oropallo M, Gaylord M, Ungaro R, Cunningham-Rundles C, Alexandropoulos K, Mucida D, Merad M, Cerutti A, Mehandru S.

J Exp Med. 2016 Jan 11;213(1):53-73. doi: 10.1084/jem.20150567. Epub 2015 Dec 28.


Phenotype and function of nasal dendritic cells.

Lee H, Ruane D, Law K, Ho Y, Garg A, Rahman A, Esterházy D, Cheong C, Goljo E, Sikora AG, Mucida D, Chen BK, Govindraj S, Breton G, Mehandru S.

Mucosal Immunol. 2015 Sep;8(5):1083-98. doi: 10.1038/mi.2014.135. Epub 2015 Feb 11.


Immune cell therapy in IBD.

Dunkin D, Mehandru S, Colombel JF.

Dig Dis. 2014;32 Suppl 1:61-6. doi: 10.1159/000367827. Epub 2014 Dec 17. Review.


Review article: the intersection of mucosal pathophysiology in HIV and inflammatory bowel disease, and its implications for therapy.

Ho TH, Cohen BL, Colombel JF, Mehandru S.

Aliment Pharmacol Ther. 2014 Nov;40(10):1171-86. doi: 10.1111/apt.12976. Epub 2014 Sep 30. Review.


Classical Flt3L-dependent dendritic cells control immunity to protein vaccine.

Anandasabapathy N, Feder R, Mollah S, Tse SW, Longhi MP, Mehandru S, Matos I, Cheong C, Ruane D, Brane L, Teixeira A, Dobrin J, Mizenina O, Park CG, Meredith M, Clausen BE, Nussenzweig MC, Steinman RM.

J Exp Med. 2014 Aug 25;211(9):1875-91. doi: 10.1084/jem.20131397. Epub 2014 Aug 18.


IBD across the age spectrum: is it the same disease?

Ruel J, Ruane D, Mehandru S, Gower-Rousseau C, Colombel JF.

Nat Rev Gastroenterol Hepatol. 2014 Feb;11(2):88-98. doi: 10.1038/nrgastro.2013.240. Epub 2013 Dec 17. Review.


Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract.

Ruane D, Brane L, Reis BS, Cheong C, Poles J, Do Y, Zhu H, Velinzon K, Choi JH, Studt N, Mayer L, Lavelle EC, Steinman RM, Mucida D, Mehandru S.

J Exp Med. 2013 Aug 26;210(9):1871-88. doi: 10.1084/jem.20122762. Epub 2013 Aug 19.


Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction.

Iglesias J, Frank E, Mehandru S, Davis JM, Levine JS.

BMC Nephrol. 2013 Jul 13;14:147. doi: 10.1186/1471-2369-14-147.


Transmitted drug resistance and phylogenetic relationships among acute and early HIV-1-infected individuals in New York City.

Castor D, Low A, Evering T, Karmon S, Davis B, Figueroa A, LaMar M, Garmon D, Mehandru S, Markowitz M.

J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):1-8. doi: 10.1097/QAI.0b013e31825a289b.


Absence of HIV-1 evolution in the gut-associated lymphoid tissue from patients on combination antiviral therapy initiated during primary infection.

Evering TH, Mehandru S, Racz P, Tenner-Racz K, Poles MA, Figueroa A, Mohri H, Markowitz M.

PLoS Pathog. 2012 Feb;8(2):e1002506. doi: 10.1371/journal.ppat.1002506. Epub 2012 Feb 2.


Flt3 signaling-dependent dendritic cells protect against atherosclerosis.

Choi JH, Cheong C, Dandamudi DB, Park CG, Rodriguez A, Mehandru S, Velinzon K, Jung IH, Yoo JY, Oh GT, Steinman RM.

Immunity. 2011 Nov 23;35(5):819-31. doi: 10.1016/j.immuni.2011.09.014. Epub 2011 Nov 10.


A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.

Pantel A, Cheong C, Dandamudi D, Shrestha E, Mehandru S, Brane L, Ruane D, Teixeira A, Bozzacco L, Steinman RM, Longhi MP.

Eur J Immunol. 2012 Jan;42(1):101-9. doi: 10.1002/eji.201141855. Epub 2011 Dec 12.


Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.

Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.

Eur J Immunol. 2010 Oct;40(10):2791-6. doi: 10.1002/eji.201040511.


Dual energy subtraction digital radiography improves performance of a next generation computer-aided detection program.

Balkman JD, Mehandru S, DuPont E, Novak RD, Gilkeson RC.

J Thorac Imaging. 2010 Feb;25(1):41-7. doi: 10.1097/RTI.0b013e3181aa34ed.


Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1.

Shet A, Mathema B, Mediavilla JR, Kishii K, Mehandru S, Jeane-Pierre P, Laroche M, Willey BM, Kreiswirth N, Markowitz M, Kreiswirth BN.

J Infect Dis. 2009 Jul 1;200(1):88-93. doi: 10.1086/599315.


The first description of severe anemia associated with acute kidney injury and adult minimal change disease: a case report.

Qian Y, Mehandru SK, Gornish N, Frank E.

J Med Case Rep. 2009 Jan 23;3:20. doi: 10.1186/1752-1947-3-20.


Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.

Prada N, Davis B, Jean-Pierre P, La Roche M, Duh FM, Carrington M, Poles M, Mehandru S, Mohri H, Markowitz M.

J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):117-22. doi: 10.1097/QAI.0b013e3181869a9b.


Role of the gastrointestinal tract in establishing infection in primates and humans.

Mehandru S, Dandekar S.

Curr Opin HIV AIDS. 2008 Jan;3(1):22-7. doi: 10.1097/COH.0b013e3282f331b0.


Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data.

Vcelar B, Stiegler G, Wolf HM, Muntean W, Leschnik B, Mehandru S, Markowitz M, Armbruster C, Kunert R, Eibl MM, Katinger H.

AIDS. 2007 Oct 18;21(16):2161-70.


Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection.

Mehandru S, Vcelar B, Wrin T, Stiegler G, Joos B, Mohri H, Boden D, Galovich J, Tenner-Racz K, Racz P, Carrington M, Petropoulos C, Katinger H, Markowitz M.

J Virol. 2007 Oct;81(20):11016-31. Epub 2007 Aug 8.

Supplemental Content

Loading ...
Support Center